In the long human negotiation between medicine and desire, a new study has surfaced a telling tension: more than one million Americans are taking GLP-1 drugs — designed for diabetes and obesity — without any documented medical condition to justify the prescription. The finding, drawn from prescription and health records, arrives against a backdrop of persistent drug shortages that have left patients with genuine diagnoses waiting months for access. It is a moment that asks an old question in a new form: when a powerful tool becomes culturally coveted, how does a society decide who deserves it?
Over 1 Million Americans Taking GLP-1 Drugs Without Medical Necessity
Health & Medicine